Next Investors Jun 27, 2023
Another month goes by, and yet another deal in the cancer cell therapy space. We Invested in Arovella Therapeutics (ASX: ALA) to see it develop and ultimately commercialise its own cell therapy cancer therapy treatment.
Next Investors Apr 21, 2022
Our biotech investment, Arovella Therapeutics (ASX:ALA), is one of only a handful of companies in the world working on an iNKT cell therapy for cancer.
Finfeed Archived Apr 17, 2020
PharmAust Limited (ASX: PAA) has entered into a Materials Transfer Agreement with the Walter and Eliza Hall Institute of Medical Research (WEHI) to test the effects of monepantel (MPL) on COVID-19 infections.
Finfeed Archived Apr 01, 2020
ImpediMed Limited (ASX: IPD) has received the first order of 16 units under the recently announced national purchasing agreement with a US oncology care network for its SOZO® Digital Health Platform and Lymphoedema Prevention Program.
Get expert stock analysis direct in your inbox
Join OurMailing List
